Multiple Sclerosis: Shall We Target CD33?
Vasileios SiokasZisis TsourisAthina-Maria AloizouChristos BakirtzisIoannis N LiampasGeorgios KoutsisMaria C AnagnostouliDimitrios P BogdanosNikolaos GrigoriadisGeorgios M HadjigeorgiouEfthimios DardiotisPublished in: Genes (2020)
Our preliminary results suggest a possible contribution of CD33 rs3865444 to MS. Therefore, larger multiethnic studies should be conducted, investigating the role of CD33 rs3865444 in MS.